DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

Isis Pharmaceuticals (NASDAQ: ISIS)

67.32 0.61 (0.91%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ISIS $67.32 0.91%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $66.67
Previous Close $66.71
Daily Range $66.51 - $68.45
52-Week Range $26.57 - $77.80
Market Cap $8.1B
P/E Ratio -333.55
Dividend (Yield) $0.00 (0.0%)
Volume 1,775,397
Average Daily Volume 2,262,475
Current FY EPS -$0.37

Sector

Healthcare

Industry

Drug Makers

Isis Pharmaceuticals (ISIS) Description

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases. Website: http://www.isispharm.com/

News & Commentary Rss Feed

The Best Business Model in Biotech

Understanding the three components that make up the best business model in biotech could make you a better investor and allow you to identify the sector's strongest stocks.

Can Isis Pharmaceuticals (ISIS) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape

IWM, GDJJ: Big ETF Outflows

Alnylam's Cardiac Amyloidosis Drug Gets Orphan Status - Analyst Blog

IWM, VGLT: Big ETF Inflows

Why I'm Buying Sarepta Therapeutics Stock

Sarepta Therapeutics got some great news from the FDA yesterday that sent shares soaring. Here's why the stock is definitely worth a deeper dive by risk-tolerant investors.

Just What Is Invested Capital Anyway?

IWM, QRVO, ISIS, JBLU: ETF Inflow Alert

4 Biotech Stocks Could Have Big Upside Before Russell Index Changes

Akers Biosciences (AKER) Q1 Earnings: What's in Store? - Analyst Blog

See More ISIS News...

ISIS's Top Competitors

ISIS $67.32 (0.91%)
Current stock: ISIS
AMGN $156.26 (-0.69%)
Current stock: AMGN
GILD $112.27 (-0.51%)
Current stock: GILD
BIIB $396.99 (-0.78%)
Current stock: BIIB